Skip to content

US · RELX · SPECIALTY BUSINESS SERVICES

RELX Plc (RELX) intrinsic value and stock valuation

$38.54as of 2026-11-21 · Mkt cap 63.92B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

RELX Plc DCF and intrinsic value

InvestorsCraft values RELX with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from RELX’s statements →

RELX Plc Graham Number

Graham Number: $5.74d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Industrials · Specialty Business Services London, GL WC2N 5JR relx.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$9.59B+6.2% 5y CAGRd
20112025
Net income
$2.07B+11% 5y CAGRd
20112025
Free cash flow
$2.82B+17.9% 5y CAGRd
20112025
Total equity
$2.39B+2.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$9.59B$9.43B$9.16B$8.55B$7.24B
Operating income$2.98B$2.86B$2.68B$2.32B$1.88B
Net income$2.07B$1.93B$1.78B$1.63B$1.47B
EPSd$1.12M$1.03M$936K$846.9K$758.5K
Operating cash flow$2.84B$2.61B$2.46B$2.4B$2.02B
Capital expenditure-$-21M-$-20M-$-477M-$-436M-$-337M
Free cash flow$2.82B$2.59B$1.98B$1.97B$1.68B
Total assets$14.7B$15.1B$14.9B$15.8B$13.9B
Total debt$7.32B$6.54B$6.5B$6.73B$6.17B
Net debt$7.19B$6.43B$6.34B$6.4B$6.05B
Total equity$2.39B$3.5B$3.44B$3.75B$3.22B
Cash and short-term investments$130.8M$119M$155M$334M$113M
Income statement
20252024202320222021
Revenue$9.59B$9.43B$9.16B$8.55B$7.24B
Cost of revenue$3.23B$3.3B$3.22B$3.05B$2.56B
Gross profit$6.36B$6.13B$5.95B$5.51B$4.68B
Research and development expenses$352M$364M$330M$309M$295M
Selling, general and administrative expenses$3.37B$3.32B$3.31B$3.2B$2.83B
Other expenses-$-396M-$-407M-$-376M$0.00$0.00
Operating expenses$3.33B$3.27B$3.26B$3.2B$2.83B
Cost and expenses$6.56B$6.57B$6.48B$6.25B$5.39B
Interest income$11.7M$9M$7M$4M$8M
Interest expense$291.5M$281M$300M$205M$150M
Depreciation and amortization$735.5M$292M$717M$785M$724M
Ebitda$3.72B$3.13B$3.31B$3.06B$2.65B
Operating income$2.98B$2.86B$2.68B$2.32B$1.88B
Total other income/expenses, net-$-233M-$-304M-$-387M-$-229M-$-87M
Income before tax$2.75B$2.56B$2.3B$2.09B$1.8B
Income tax expense$672M$613M$507M$481M$326M
Net income$2.07B$1.93B$1.78B$1.63B$1.47B
Weighted average shares outstanding$1.83B$1.88B$1.9B$1.92B$1.93B
Weighted average diluted shares outstanding$1.84B$1.88B$1.9B$1.93B$1.94B
Balance sheet
20252024202320222021
Cash and short-term investments$130.8M$119M$155M$334M$113M
Net receivables$2.46B$2.47B$2.03B$2.41B$1.96B
Inventory$310.5M$331M$318M$309M$253M
Total current assets$2.95B$3B$2.87B$3.07B$2.36B
Property, plant and equipment, net$158.7M$171M$212M$271M$292M
Goodwill and intangible assets$11B$11.4B$11.3B$11.9B$10.7B
Long-term investments$363.4M$261M$275M$302M$283M
Total non-current assets$11.8B$12.1B$12B$12.8B$11.5B
Total assets$14.7B$15.1B$14.9B$15.8B$13.9B
Accounts payable$4.25B$223M$171M$129M$109M
Short-term debt$1.6B$1.41B$1.31B$870M$232M
Deferred revenue$0.00$0.00$0.00$2.37B$1.96B
Total current liabilities$5.98B$5.72B$5.49B$5.19B$3.75B
Long-term debt$5.75B$5.13B$5.18B$5.86B$5.94B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$6.36B$5.91B$5.99B$6.89B$6.89B
Capital lease obligations$96.9M$103M$141M$182M$208M
Total liabilities$12.3B$11.6B$11.5B$12.1B$10.6B
Common stock$263.5M$272M$275M$279M$286M
Retained earnings$0.00$0.00$0.00$0.00$0.00
Accumulated other comprehensive income (loss)$128.8M$0.00$2.18B$2.39B$2.33B
Total equity$2.39B$3.5B$3.44B$3.75B$3.22B
Total investments$363.4M$261M$275M$302M$283M
Total debt$7.32B$6.54B$6.5B$6.73B$6.17B
Net debt$7.19B$6.43B$6.34B$6.4B$6.05B
Cash flow statement
20252024202320222021
Net income$2.07B$1.93B$1.78B$2.32B$1.88B
Depreciation and amortization$752M$783M$717M$713M$724M
Stock-based compensation$63M$66M$56M$46M$45M
Change in working capital-$-87M-$-146M-$-114M-$-74M-$-148M
Accounts receivable$14M$0.00-$-24M-$-251M-$-103M
Inventory-$-101M$0.00-$-90M-$-103M-$-13M
Accounts payable$0.00$0.00-$-1M$0.00-$-32M
Net cash provided by operating activities$2.84B$2.61B$2.46B$2.4B$2.02B
Investments in property, plant and equipment-$-21M-$-20M-$-30M-$-36M-$-337M
Acquisitions, net-$-260M-$-170M-$-112M-$-390M-$-64M
Net cash used for investing activities-$-770M-$-575M-$-569M-$-859M-$-384M
Common stock issued$0.00-$-28M-$-9M-$-24M$32M
Common stock repurchased-$-1.58B-$-1B-$-800M-$-500M-$-1M
Dividends paid-$-1.18B-$-1.12B-$-1.06B-$-983M-$-920M
Net cash used for financing activities-$-2.05B-$-2.07B-$-2.06B-$-1.33B-$-1.61B
Net change in cash$12M-$-36M-$-179M$221M$25M
Cash at end of period$131M$119M$155M$334M$113M
Operating cash flow$2.84B$2.61B$2.46B$2.4B$2.02B
Capital expenditure-$-21M-$-20M-$-477M-$-436M-$-337M
Free cash flow$2.82B$2.59B$1.98B$1.97B$1.68B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About RELX Plc

        RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.

        CEO
        Erik Engstrom
        Employees
        37K
        Beta
        0.26

        Explore

        Frequently asked questions

        What is the intrinsic value of RELX Plc (RELX)?

        RELX Plc (RELX) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is RELX undervalued?

        RELX trades at a price of $38.54 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.